1. The New Landscape of ABSSTI Treatment Opportunities to Improve Patient Care

3. ABSSTI Burden of Disease

4. ABSSTI Implications

5. Defining ABSSTI

6. Defining ABSSTI (cont)

7. Management of ABSSTI

8. Therapeutic Landscape Antimicrobial Therapy for Staphylococcal and Streptococcal ABSSTI

9. Adding to the Armamentarium Against ABSSTI Novel Agents

10. Relative Advantages and Disadvantages of Novel Agents for Treatment of ABSSTI

11. The Patient Who Presents to the ED With ABSSTI Admit to Hospital?

12. The Patient Who Presents to the ED With ABSSTI Discharge Home?

13. Should Cultures Be Done for All Patients With ABSSTI?

14. Is Double-empiric Therapy Indicated for Uncomplicated ABSSTI?

15. Is Double-empiric Therapy Indicated for Complicated ABSSTI? (cont)

16. Guidelines Lag Behind Advances Novel Long-acting Antibiotics

17. De-escalation and Duration of Antibiotic Therapy Important Stewardship Principles

18. Guidelines Are Guidelines

19. Do Patients Managed With I&D Need Antibiotics?

20. ED Primary Point of Entry for Patients With ABSSTI Due to MRSA

21. Care Transitions in the Emergency Department Streamlining Across the Continuum of Care and Standardizing the Management of ABSSTI

22. Abbreviations

23. Abbreviations (cont)

24. References

25. References (cont)

26. References (cont)

27. References (cont)

28. References (cont)